Analysis of the effect of recombinant human growth hormone therapy on metabolic parameters in patients with severe growth hormone deficiency in adulthood
Endokrynologia Polska · 30.06.2026 · 77 (3) · 172-181
DOI: 10.5603/ep.110442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endokrynologia Polska, online erschienen am 30.06.2026. Verfasst von Zuzanna Żak-Skryśkiewicz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Endocrinology and Diabetes, Medical University of Warsaw, Warsaw, Poland. zuzanna.zak@wum.edu.pl. Hauptthemen laut MEDLINE: Human Growth Hormone.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Endocrinology and Diabetes, Medical University of Warsaw, Warsaw, Poland. zuzanna.zak@wum.edu.pl.
- Department of Internal Medicine, Endocrinology and Diabetes, Medical University of Warsaw, Warsaw, Poland.
ORCID-Profile: Zuzanna Żak-Skryśkiewicz, Lukasz Dzialach, Przemysław Witek
Zitieren
APA
Żak-Skryśkiewicz, Z., Dzialach, L., & Witek, P. (2026). Analysis of the effect of recombinant human growth hormone therapy on metabolic parameters in patients with severe growth hormone deficiency in adulthood. Endokrynologia Polska, 77(3), 172-181. https://doi.org/10.5603/ep.110442
Vancouver
Żak-Skryśkiewicz Z, Dzialach L, Witek P. Analysis of the effect of recombinant human growth hormone therapy on metabolic parameters in patients with severe growth hormone deficiency in adulthood. Endokrynologia Polska. 2026;77(3):172-181. doi:10.5603/ep.110442
BibTeX
@article{akSkrykiewicz2026,
author = {Żak-Skryśkiewicz, Zuzanna and Dzialach, Lukasz and Witek, Przemysław},
title = {Analysis of the effect of recombinant human growth hormone therapy on metabolic parameters in patients with severe growth hormone deficiency in adulthood},
journal = {Endokrynologia Polska},
year = {2026},
volume = {77},
number = {3},
pages = {172--181},
doi = {10.5603/ep.110442}
}
EUVIMED